Levothyroxine Sodium
- Product NDC
- 50090-5661
- 11-digit product format
- 500905661
- Labeler code
- 50090
- Product ID
- 50090-5661_1e19851f-6d5f-4340-9aac-03b099060f56
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- NDA021342
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2020-08-03
- Marketing end
- 0000-00-00
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 50 ug/1
- Pharmacologic classes
- l-Thyroxine [EPC],Thyroxine [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5661-0 | 50090566100 | 30 TABLET in 1 BOTTLE (50090-5661-0) | 30 tablet | 2021-09-15 | 0000-00-00 | No | No | Current |
| 50090-5661-1 | 50090566101 | 90 TABLET in 1 BOTTLE (50090-5661-1) | 90 tablet | 2021-09-15 | 0000-00-00 | No | No | Current |